Clinical Trials Directory

Trials / Completed

CompletedNCT00332267

Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of the present protocol is to study whether a low level of oxygen in the blood will affect the immune response to as well as cerebral blood flow and metabolism during an infection and, conversely, whether the acute systemic and cerebral physiologic response to hypoxia is modified by an ongoing inflammatory response.

Detailed description

The combination of acute infection and a low level of oxygen in the blood is a common phenomenon. Thus, acute hypoxia may complicate severe infections including severe sepsis. Conversely, healthy persons who ascend to moderately high altitudes, which will be associated with a lowering of the inspired oxygen level, may sustain an infection. Even so, it is unknown whether hypoxia modifies the systemic inflammatory response, or, conversely, whether the reaction to hypoxia is influenced by the presence of systemic inflammation. The present protocol aims to measure global cerebral blood flow, metabolism and net flux as well as the systemic response in healthy volunteers who are subjected to either normobaric hypoxia alone (N=12), low-dose IV endotoxin infusion alone (N=12), or a combination of endotoxin infusion and normobaric hypoxia (N=12).

Conditions

Interventions

TypeNameDescription
PROCEDUREEndotoxin infusion, Normobaric hypoxia

Timeline

Start date
2006-05-01
Primary completion
2006-07-01
Completion
2006-07-01
First posted
2006-06-01
Last updated
2008-09-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00332267. Inclusion in this directory is not an endorsement.